Jones Financial Companies
COYA icon

Jones Financial Companies’s Coya Therapeutics COYA Stock Holding History

Jones Financial Companies’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Buy
44,960
+39,883
+786% +$186K ﹤0.01% 2448
2025
Q4 		$29.4K Buy
+5,077
New +$30.9K ﹤0.01% 2768
2025
Q1 		– Sell
-600
Closed -$3.44K – 3741
2024
Q4 		$3.44K Sell
600
-5,450
-90% -$37.1K ﹤0.01% 2866
2024
Q3 		$40.9K Buy
+6,050
New +$38.2K ﹤0.01% 1715

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jones Financial Companies's COYA Position: Q1 2026 in Review

Jones Financial Companies increased its Coya Therapeutics (COYA) stake by 786% in Q1 2026, buying an estimated $186K and bringing the position to 44,960 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #2448.

Jones Financial Companies first reported a position in COYA in Q3 2024 and has held it in 4 quarters since. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Jones Financial Companies held 44,960 shares of Coya Therapeutics worth $178K as of Q1 2026.
  • Jones Financial Companies bought 39,883 Coya Therapeutics shares in Q1 2026, an estimated $186K.
  • Coya Therapeutics made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #2448 holding.
  • Jones Financial Companies first reported a position in Coya Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.